E2F transcription factor 1 overexpression as a poor prognostic factor in patients with nasopharyngeal carcinomas

Abstract Nasopharyngeal carcinoma (NPC) is an endemic head and neck epithelial malignancy in Southeastern Asia and Taiwan. The E2 factor (E2F) family of transcription factors is downstream targets of the retinoblastoma protein 1. The E2F family of transcription factors is the key regulator of genes...

Full description

Saved in:
Bibliographic Details
Published in:Biomarkers and genomic medicine 2013-03, Vol.5 (1), p.23-30
Main Authors: Li, Chien-Feng, Chen, Li-Tzong, Lin, Ching-Yih, Huang, Hsuan-Ying, Hsing, Chung-Hsi, Huang, Chiang-Ting, Shiue, Yow-Ling
Format: Article
Language:English
Subjects:
Advanced Basic Science
E2F transcription factor 1
Medical Education
nasopharyngeal carcinoma
survival
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Nasopharyngeal carcinoma (NPC) is an endemic head and neck epithelial malignancy in Southeastern Asia and Taiwan. The E2 factor (E2F) family of transcription factors is downstream targets of the retinoblastoma protein 1. The E2F family of transcription factors is the key regulator of genes involved in cell cycle progression, cell fate determination, DNA damage repair and apoptosis. E2F1 is unique in that it contributes both to the control of cellular proliferation and cellular death. However, the expression of E2F1 protein and its clinicopathological associations in patients with NPC are yet to be evaluated. Immunoexpression of E2F1 was retrospectively assessed in biopsies of 124 consecutive NPC patients without initial distant metastasis and treated with consistent guidelines. The outcomes were correlated with clinicopathological features and patient survivals. Results indicated that high E2F1 protein level (50%) was correlated with primary tumor ( p  
ISSN:2214-0247
2214-0255
DOI:10.1016/j.gmbhs.2013.04.006